Archived Literature
Here you can find all of our featured articles and editorials from our previous newsletters
-
RESPECT TO CONNECT: UNDOING STIGMA
Recommended Use of Terminology in Addiction Medicine
Physician Use of Stigmatizing Language in patient Medical Records
Stigmatization of MOUD in 12-Step Support Groups and Participant Responses
Health Care Professionals’ Attitudes Toward Medications for Opioid Use Disorder
-
Telehealth Shouldn’t Mean “Videohealth” for Opioid Treatment
No “Back to Normal” for Our Failed Drug Policies
Why Pharmacies May be Hesitant to Dispense Buprenorphine
Increasingly Powerful Opioid Antagonists are Not Necessary
Opinion: Inaction Won’t Cut it. We Need to Solve the Overdose Crisis Now.
Addiction Should be Treated, Not Penalized
A Primer and “Research Roundup” on Racial Disparities in Opioid Addiction Treatment
The ‘Safe Supply’ Movement Aims to Curb Drug Deaths Linked to the Opioid Crisis
-
Video: Overdoses Rising, Vaping, Fentanyl and Stimulants Trending, Addiction Expert Says
A Record 100K Overdose Deaths Occurred OVER ONE-Year During COVID-19
New Opioids, More Powerful Than Fentanyl, Are Discovered In D.C. Amid Deadly Wave Of Overdoses
Experts Question Viral Video of San Diego Deputy’s Fentanyl Encounter
Atlantic City Voted to Shut Down the City’s Only Syringe Access Program
The DEA Seizes Nearly 2 Million Fentanyl-Laced Pills in a National Crackdown
New York City Allows The Nation’s 1st Supervised Consumption Sites For Illegal Drugs
-
Harm Reduction, Expanding Treatment Access Included in White House Drug Policy Priorities
Harm Reduction by Mail: The Next Step in Promoting the Health of People Who Use Drugs (PWUDs)
Syringe Distribution Programs May Help Reduce Opioid Overdose Deaths
Attitudes Toward Syringe Exchange Programs in a Rural Appalachian Community
Follow-Up: Drug Sellers’ Stories
Impact of an Unsanctioned Safe Consumption Site on Criminal Activity, 2010-2019
Rhode Island Becomes the First State to Support Pilot Harm Reduction Center
Understanding Harm Reduction, Syringe Service Program (SSP) Utilization In a Rural State
-
Buprenorphine Maintenance Linked To Reduced Opioid Prescriptions And Overdose Deaths
What Are The Key Motivators For Treatment With Diverted Buprenorphine?
Do Residential Treatment Programs Routinely Offer MAT?
What Are The Risks With Discontinuing Long Term Buprenorphine Use?
The Relationship Between Cannabis Use And Patient Outcomes In Medication-Based Treatment Of OUD
Treatment Strategies for Precipitated Withdrawal After Naloxone Rescue
Retention Strategies for MOUD in Adults: A Rapid Evidence Review
What is Associated with Adherence to Buprenorphine?
Take-Home Dosing Experiences Among Persons Receiving Methadone Maintenance Treatment During COVID-19
Policies Should Promote Access to Buprenorphine for Opioid Use Disorder
High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder
Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review
Buprenorphine Dispensing in Pennsylvania During COVID-19 Pandemic, January–October 2020
Polysubstance Use Among Patients Treated with Buprenorphine From a National Urine Drug Test Database
Home Induction of Buprenorphine for Pregnant Women
Is More Frequent Use Of Non-Prescribed Buprenorphine Associated With Lower Risk Of Overdose?
Treatment of Opioid Use Disorder in Primary Care
Medications for Opioid Use Disorder in Jails and Prisons: Moving Toward Universal Access
Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl
Opioid Agonist Therapy Reduces Fatal Overdose By 60% In A Population Of Justice Involved Adults
Do Buprenorphine-Waivered Clinicians Treat Close To Their Patient Limits?
-
Primary Care Providers And Specialists Deliver Comparable Buprenorphine Treatment Quality
Is Cannabis Being Used As A Substitute To Decrease Opioid Use In OUD?
Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook
A Quantitative Analysis Of Outcomes Of A Novel Hydromorphone Tablet Distribution Program In Canada
Unlocking Federal Funding for Fentanyl Test Strips Will Save Lives
The Push for Increased Access to Naloxone on College Campuses
“A Shot Against Opioids”: Development of a Vaccine to Prevent the Euphoric Effects of Opioids
New Approaches to Help Emergency Rooms Help Those with Addiction
Research Priorities for Expanding Access to Methadone Treatment for Opioid Use Disorder in the U.S.
Registration Requirements for Narcotic Treatment Programs (NTP) with Mobile Components
Bridge Clinic Buprenorphine Program Decreases Emergency Department Visits
Receipt of MOUD Among Youth Engaged in Primary Care: Data from 6 Health Systems
-
Medicaid Expansion Increased Use of MOUD Among Individuals with Criminal Justice Involvement
Murphy Administration Seeks to Expand Program to Get Emergency Rooms to Use Fewer Opioids
FDA Approves Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose
The Number Needed to Prescribe – What Does it Take to Expand Access to Buprenorphine?
Medicaid Participation Among Practitioners Authorized to Prescribe Buprenorphine
Governor Murphy Signs Legislative Initiative to Address New Jersey’s Opioid Epidemic
New Police Program in Chicago Helps People Using Drugs Get SUD Treatment Instead of Jail Time
New Federal Strategy Focusing on the Needs of People with Addiction to Combat Overdoses
DEA Disconnect Leads to Buprenorphine Bottlenecks
The Evolving Medicolegal Precedent for MOUD in U.S. Jails and Prisons
Hospitals May be Violating Federal Laws by Denying Necessary Care for SUD’s in Emergency Departments
Understanding the Barriers to Opioid Use Disorder As it Relates to the Failed HHS Guidance
-
What Are The Structural Vulnerabilities Linked To Abusive Policing Among People Who Inject Drugs?
Reporting of SUD Treatment Quality in U.S. Adult Drug Courts
Lack of Access to Medications for Opioid Use Disorder in Federal Prisons
Maintaining Recovery from Alcohol Use Disorder During the Covid-19 Pandemic
-
Multimorbidity and Inpatient Utilization Among Older Adults with OUD in NYC
Is There “Compassion Fatigue” Amongst Law Enforcement Who Respond To Overdoses?
Has the Opioid Crisis Played a Role in Psychostimulant-Overdose Mortality in States across the US?
Assessment of Annual Cost of Substance Use Disorder in US Hospitals
Is There An Association Between Child Removal And Unintentional Drug Overdose?
Causes of Death in the 12 Months After Hospital Discharge Among Patients with OUD
Injection Drug Use & Health Care Utilization in Patients Newly Diagnosed with HIV
-
Illicit Drug Use While Admitted to Hospital: Patient and Health Care Provider Perspectives
Complex Persistent Opioid Dependence with Long-term Opioids
Perceived Occupational Risk of Fentanyl Exposure Among Law Enforcement
Opioid Use Disorder: A Neglected Human Immunodeficiency Virus Risk in American Adolescents
Combining Opioid Use Disorder Treatment with Prenatal Care: A Missouri Initiative
Treatment Outcomes in Individuals Diagnosed with Comorbid OUD & PTSD